Skip to content
Open access

Spatially resolved proteomics provides insights into the normal-dysplasia-tumor continuum in oral squamous cell carcinoma.

Jul 2026 · BMC Oral Health · 0 citations
Medicine

TL;DR

Spatially resolved proteomics of archived formalin-fixed paraffin-embedded tissues provides a morphology-anchored proteomic continuum of oral malignant transformation in a small spatially matched cohort, suggesting that OSCC progression involves early-shift, progressive, and transient dysplasia-specific programs.

Abstract

Background

Oral epithelial dysplasia is a recognized precursor lesion for oral squamous cell carcinoma (OSCC), yet the proteomic changes underlying the progression from normal epithelium to dysplasia and ultimately to OSCC remain incompletely characterized. This gap is partially due to the high interpatient heterogeneity of OSCC, the frequent reliance on cross-patient comparisons, and the omission of dysplasia as a critical intermediate stage.

Methods

A histology-guided, spatially resolved proteomics workflow was applied to formalin-fixed paraffin-embedded tissue blocks from six patients with primary OSCC. For each case, spatially contiguous normal (N), dysplasia (D), and tumor (T) regions from the same lesion-bearing block, yielding 18 regional proteomes. Proteins were profiled using data-independent acquisition liquid chromatography-tandem mass spectrometry. Downstream analyses included differential expression analysis, Gene Ontology and Kyoto Encyclopedia of Genes and Genomes enrichment, soft-clustering trajectory analysis, protein-protein interaction analysis, exploratory clinicopathological stratification, and immunohistochemistry validation.

Results

The spatially matched N-D-T dataset identified 1,683 proteins in N, 2,100 in D, and 1,966 in T. Under the predefined differential-expression threshold, the N vs. D comparison yielded more differentially expressed proteins than the D vs. T comparison, suggesting that threshold-detectable proteomic alterations may already be present at dysplasia. Functionally, the N-to-D transition was associated with cell-cycle activation, proliferative signaling, hypoxia-associated responses, and metabolic alterations, whereas the D-to-T transition was more closely related to cytoskeletal organization, motor activity, and structural remodeling. Across the overall N-to-T contrast, glycolysis, pyruvate metabolism, and broader metabolic reprogramming predominated. Trajectory analysis resolved Early Warning, Progression, and dysplasia-restricted transient modules, suggesting a non-linear architecture of proteomic evolution during OSCC progression. MYO1B showed progression-associated spatial increase from N to D and T regions, whereas HSP90AB1 was prioritized as a candidate invasion-associated hub supported by proteomic, protein-protein interaction network, and external transcriptomic analyses.

Conclusions

Spatially resolved proteomics of archived formalin-fixed paraffin-embedded tissues provides a morphology-anchored proteomic continuum of oral malignant transformation in a small spatially matched cohort. The data suggest that OSCC progression involves early-shift, progressive, and transient dysplasia-specific programs. These findings offer candidate proteins and biological hypotheses for further validation in larger oral cancer cohorts.

Read PDF

Similar papers

Open access Jul 2026

Spatial transcriptomics reveals molecular differences associated with malignant transformation in oral epithelial dysplasia

Spatial transcriptomics is applied to characterize benign, OED and OSCC biopsies with a focus on the comparison between transforming and non-transforming OED lesions, suggesting altered epithelial-immune interactions in transforming lesions, though these findings require validation.

Naren Raja, H. Pathak, Amrita Mitra et al. · 0 citations
Open access Aug 2026

Spatial transcriptomics reveals site-specific cellular and metabolic heterogeneity in bladder carcinoma in situ

Results demonstrate that CIS exhibits significant intra-patient heterogeneity not captured by single-site profiling, and support multi-region sampling, which could help improve risk stratification, biomarker development, and prediction of response to intravesical therapies.

Tyler D. Myers, A. Salmasi, M. Meagher et al. · 0 citations
Open access Jul 2026

Molecular Insights from Differential Proteomic Profiling of Premalignant Cervical Lesions and Cervical Cancer

This study identified differentially expressed proteins (DEPs) associated with the progression of premalignant lesions to SCC that may represent candidate biomarkers and therapeutic targets warranting further investigation.

Diana Laura Gonzalez-Tolentino, O. L. Garibay-Cerdenares, S. Encarnación-Guevara et al. · 0 citations
Open access Aug 2026

Spatial and Multi-Omics Analysis of Human Breast Cancer Reveals the Spatiotemporal Dynamics of Basal Layer Disruption

Findings support a model in which progression-relevant breast tissue remodeling may begin at the DH stage and nominate cellular states and candidate biomarkers for prospective validation in breast cancer risk stratification among patients with DH.

Siwei Ju, Zhanzhi Li, Li-Dan Jin et al. · 0 citations
Aug 2026

P1.108. Molecular Determinants of Tumor Morphology in Esophageal Adenocarcinoma

The first validated morpho-molecular classification of Esophageal adenocarcinoma is reported, with the transitional and signet ring signatures associated with worse prognosis compared to tumors with a glandular signature.

G. Wilson, Jin-soo Park, F. Allison et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.